Back

From the selectivity to the clinical and pharmacoeconomic outcomes.

29 August 2016 (13:00 - 13:20)
Organised by:
Congress Presentation Part of: Vasodilating betablockers for our patients. Why to prefer them? Pharmacologic therapy ESC Premium Access ESC Congress 2016

About the speaker

Photo
Professor Franz Messerli

Lucerne Cantonal Hospital, Luzern (Switzerland)

1 More presentation in this session

Presentation thumbnail
Betablockers in fixed dose combinations: what’s new?
Professor G. Mancia (Milan, IT)

Access the full session

Session thumbnail
Vasodilating betablockers for our patients. Why to prefer them?

The Event

Event poster

ESC Congress 2016

29 August 2016 13:00 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources